We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 25, 2021

Efficacy and Safety of Trametinib in Non-V600 BRAF–Mutant Melanoma

The Oncologist


Additional Info

The Oncologist
Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study
Oncologist 2021 Sep 01;26(9)731-e1498, CA Nebhan, DB Johnson, RJ Sullivan, RN Amaria, KT Flaherty, JA Sosman, MA Davies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading